China Sxt Pharmaceuticals Inc
(SXTC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2020 | 03-2020 | 09-2019 | 03-2019 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,381 | -10,288 | N/A | 1,539 | N/A |
| Depreciation Amortization | 183 | 332 | N/A | 181 | N/A |
| Other Working Capital | -2,431 | 1,947 | N/A | -1,540 | N/A |
| Other Operating Activity | 533 | 8,943 | 0 | 59 | 0 |
| Operating Cash Flow | $-334 | $934 | $N/A | $239 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -119 | -407 | N/A | -599 | N/A |
| Other Investing Activity | 2,857 | -5,090 | 0 | -11 | 0 |
| Investing Cash Flow | $2,738 | $-5,497 | $N/A | $-610 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 274 | 3,024 | 0 | 9,042 | 0 |
| Financing Cash Flow | $274 | $3,024 | $N/A | $9,042 | $N/A |
| Exchange Rate Effect | 387 | -467 | N/A | -37 | N/A |
| Beginning Cash Position | 7,287 | 9,292 | N/A | 658 | N/A |
| End Cash Position | 10,353 | 7,287 | N/A | 9,292 | N/A |
| Net Cash Flow | $3,066 | $-2,005 | $N/A | $8,634 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -334 | 934 | N/A | 239 | N/A |
| Free Cash Flow | -334 | 934 | 0 | 239 | 0 |